You are here

epilepsy

Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

BioSpace

Thu, 08/18/22 - 12:45 pm

clinical trials

After rejection, Azurity gets FDA nod for liquid epilepsy drug

Fierce Pharma

Tue, 07/19/22 - 10:30 am

French court rules against Sanofi in landmark Depakine case

Endpoints

Tue, 05/17/22 - 10:33 am

FDA tells Praxis it can't move into the clinic just yet for a rare epilepsy drug

Endpoints

Fri, 04/29/22 - 10:45 am

Praxis Precision Medicines

Controversial opioid Zohydro ER pulled from the market

Endpoints

Thu, 02/3/22 - 12:00 am

Ovid signs license deal with AstraZeneca to expand epilepsy drug pipeline

Pharmaceutical Business Review

Tue, 01/4/22 - 10:16 am

Ovid Therapeutics

small molecule drugs

Canada's Xenon touts out-of-the-blue win for its daily epilepsy pill, sending investors into a frenzy

Endpoints

Mon, 10/4/21 - 11:05 am

clinical trials

Neuroelectrics gets $17M for new take on electrical therapy for epilepsy, depression

MedCity News

Wed, 05/5/21 - 10:48 am

electrical therapy

Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy

Stat

Wed, 02/3/21 - 10:58 am

UCB backs epilepsy-focused digital heath startup Nile AI

Pharmaforum

Fri, 01/15/21 - 10:02 am

artificial intelligence

In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate

Endpoints

Mon, 01/4/21 - 10:41 am

Arvelle Therapeutics

Angelini Pharma

Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

Pharmaceutical Business Review

Wed, 11/18/20 - 11:59 am

Cerebral Therapeutics

clinical trials

France’s Medicine Watchdog Indicted Over Sanofi’s Birth Defect-Causing Drug

BioSpace

Sat, 11/14/20 - 02:00 pm

Ovid shows mixed results on epilepsy program

Endpoints

Wed, 09/30/20 - 10:49 pm

Ovid Therapeutics

clinical trials

Epilepsy gene therapy candidate moves closer to clinical study phase

Biopharma Reporter

Thu, 09/17/20 - 10:46 am

Cobra Biologics

Sanofi faces manslaughter charges in France over yearslong Depakine probe

Fierce Pharma

Mon, 08/3/20 - 11:27 pm

FDA Approves Zogenix's Drug for Rare Childhood Epilepsy

NY Times, NY

Fri, 06/26/20 - 09:46 am

Dravet syndrome

UCB buys epilepsy firm Engage Tx in $270m deal

PM Live

Mon, 06/8/20 - 10:30 am

Engage Therapeutics

drug-device combos

Staccato Alprazolam

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

Xconomy

Mon, 05/4/20 - 10:34 pm

Praxis Precision Medicines

Redpin Launches with $15.5 Million Series A to Focus on Pain and Epilepsy

BioSpace

Wed, 03/25/20 - 10:38 am

Redpin Therapeutics

Pages